UniProt ID | MYBB_HUMAN | |
---|---|---|
UniProt AC | P10244 | |
Protein Name | Myb-related protein B | |
Gene Name | MYBL2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 700 | |
Subcellular Localization | Nucleus. | |
Protein Description | Transcription factor involved in the regulation of cell survival, proliferation, and differentiation. Transactivates the expression of the CLU gene.. | |
Protein Sequence | MSRRTRCEDLDELHYQDTDSDVPEQRDSKCKVKWTHEEDEQLRALVRQFGQQDWKFLASHFPNRTDQQCQYRWLRVLNPDLVKGPWTKEEDQKVIELVKKYGTKQWTLIAKHLKGRLGKQCRERWHNHLNPEVKKSCWTEEEDRIICEAHKVLGNRWAEIAKMLPGRTDNAVKNHWNSTIKRKVDTGGFLSESKDCKPPVYLLLELEDKDGLQSAQPTEGQGSLLTNWPSVPPTIKEEENSEEELAAATTSKEQEPIGTDLDAVRTPEPLEEFPKREDQEGSPPETSLPYKWVVEAANLLIPAVGSSLSEALDLIESDPDAWCDLSKFDLPEEPSAEDSINNSLVQLQASHQQQVLPPRQPSALVPSVTEYRLDGHTISDLSRSSRGELIPISPSTEVGGSGIGTPPSVLKRQRKRRVALSPVTENSTSLSFLDSCNSLTPKSTPVKTLPFSPSQFLNFWNKQDTLELESPSLTSTPVCSQKVVVTTPLHRDKTPLHQKHAAFVTPDQKYSMDNTPHTPTPFKNALEKYGPLKPLPQTPHLEEDLKEVLRSEAGIELIIEDDIRPEKQKRKPGLRRSPIKKVRKSLALDIVDEDVKLMMSTLPKSLSLPTTAPSNSSSLTLSGIKEDNSLLNQGFLQAKPEKAAVAQKPRSHFTTPAPMSSAWKTVACGGTRDQLFMQEKARQLLGRLKPSHTSRTLILS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Phosphorylation | ---MSRRTRCEDLDE ---CCCCCCCCCHHH | 38.26 | 28111955 | |
15 | Phosphorylation | EDLDELHYQDTDSDV CCHHHHHCCCCCCCC | 22.25 | 30576142 | |
18 | Phosphorylation | DELHYQDTDSDVPEQ HHHHCCCCCCCCCCH | 23.13 | 23898821 | |
20 | Phosphorylation | LHYQDTDSDVPEQRD HHCCCCCCCCCCHHC | 42.47 | 22617229 | |
28 | Phosphorylation | DVPEQRDSKCKVKWT CCCCHHCCCCCCEEC | 41.99 | 21498570 | |
33 | Ubiquitination | RDSKCKVKWTHEEDE HCCCCCCEECCCHHH | 31.69 | 29967540 | |
93 | Sumoylation | WTKEEDQKVIELVKK CCHHHHHHHHHHHHH | 58.46 | - | |
93 | Sumoylation | WTKEEDQKVIELVKK CCHHHHHHHHHHHHH | 58.46 | - | |
104 | Sumoylation | LVKKYGTKQWTLIAK HHHHHCCHHHHHHHH | 39.20 | - | |
104 | Sumoylation | LVKKYGTKQWTLIAK HHHHHCCHHHHHHHH | 39.20 | 28112733 | |
110 | Ubiquitination | TKQWTLIAKHLKGRL CHHHHHHHHHHHHHH | 9.05 | 29967540 | |
127 | Ubiquitination | QCRERWHNHLNPEVK HHHHHHHHHCCHHHH | 34.09 | 29967540 | |
134 | Sumoylation | NHLNPEVKKSCWTEE HHCCHHHHHHCCCHH | 36.99 | - | |
134 | Sumoylation | NHLNPEVKKSCWTEE HHCCHHHHHHCCCHH | 36.99 | - | |
134 | Ubiquitination | NHLNPEVKKSCWTEE HHCCHHHHHHCCCHH | 36.99 | 29967540 | |
135 | Ubiquitination | HLNPEVKKSCWTEEE HCCHHHHHHCCCHHH | 56.90 | - | |
136 | Phosphorylation | LNPEVKKSCWTEEED CCHHHHHHCCCHHHH | 14.79 | 25404012 | |
138 | Ubiquitination | PEVKKSCWTEEEDRI HHHHHHCCCHHHHHH | 17.59 | 29967540 | |
149 | Ubiquitination | EDRIICEAHKVLGNR HHHHHHHHHHHHHHH | 11.91 | 29967540 | |
151 | Ubiquitination | RIICEAHKVLGNRWA HHHHHHHHHHHHHHH | 46.32 | 29967540 | |
157 | Ubiquitination | HKVLGNRWAEIAKML HHHHHHHHHHHHHHC | 11.40 | 29967540 | |
159 | Ubiquitination | VLGNRWAEIAKMLPG HHHHHHHHHHHHCCC | 36.20 | 29967540 | |
162 | Ubiquitination | NRWAEIAKMLPGRTD HHHHHHHHHCCCCCC | 46.78 | 29967540 | |
168 | Phosphorylation | AKMLPGRTDNAVKNH HHHCCCCCCHHHHHH | 39.25 | 26074081 | |
173 | Ubiquitination | GRTDNAVKNHWNSTI CCCCHHHHHHHHHCH | 40.46 | 29967540 | |
178 | Phosphorylation | AVKNHWNSTIKRKVD HHHHHHHHCHHCCCC | 26.73 | 25159151 | |
181 | Ubiquitination | NHWNSTIKRKVDTGG HHHHHCHHCCCCCCC | 46.37 | 29967540 | |
183 | Ubiquitination | WNSTIKRKVDTGGFL HHHCHHCCCCCCCCC | 39.19 | 29967540 | |
194 | Sumoylation | GGFLSESKDCKPPVY CCCCCCCCCCCCCEE | 64.19 | 28112733 | |
197 | Sumoylation | LSESKDCKPPVYLLL CCCCCCCCCCEEEEE | 63.59 | - | |
197 | Sumoylation | LSESKDCKPPVYLLL CCCCCCCCCCEEEEE | 63.59 | 28112733 | |
234 | Phosphorylation | NWPSVPPTIKEEENS CCCCCCCCCCCCCCC | 38.31 | - | |
236 | Sumoylation | PSVPPTIKEEENSEE CCCCCCCCCCCCCHH | 62.64 | - | |
241 | Phosphorylation | TIKEEENSEEELAAA CCCCCCCCHHHHHHH | 50.06 | 29255136 | |
242 | Phosphorylation | IKEEENSEEELAAAT CCCCCCCHHHHHHHH | 68.05 | 32142685 | |
249 | Phosphorylation | EEELAAATTSKEQEP HHHHHHHHCCCCCCC | 27.20 | 26074081 | |
250 | Phosphorylation | EELAAATTSKEQEPI HHHHHHHCCCCCCCC | 32.83 | 26074081 | |
251 | Phosphorylation | ELAAATTSKEQEPIG HHHHHHCCCCCCCCC | 29.82 | 26074081 | |
259 | Phosphorylation | KEQEPIGTDLDAVRT CCCCCCCCCCHHCCC | 33.82 | 22199227 | |
266 | Phosphorylation | TDLDAVRTPEPLEEF CCCHHCCCCCCHHHC | 25.96 | 30266825 | |
275 | Sumoylation | EPLEEFPKREDQEGS CCHHHCCCCCCCCCC | 73.98 | 28112733 | |
282 | Phosphorylation | KREDQEGSPPETSLP CCCCCCCCCCCCCCC | 36.21 | 23401153 | |
286 | Phosphorylation | QEGSPPETSLPYKWV CCCCCCCCCCCHHHH | 41.14 | 23663014 | |
287 | Phosphorylation | EGSPPETSLPYKWVV CCCCCCCCCCHHHHH | 26.19 | 29255136 | |
290 | Phosphorylation | PPETSLPYKWVVEAA CCCCCCCHHHHHHHH | 23.83 | 23186163 | |
362 | Phosphorylation | VLPPRQPSALVPSVT CCCCCCCCCCCCCEE | 26.37 | - | |
384 | Phosphorylation | TISDLSRSSRGELIP CHHHCCCCCCCCEEE | 22.47 | 23090842 | |
385 | Phosphorylation | ISDLSRSSRGELIPI HHHCCCCCCCCEEEC | 43.10 | 23090842 | |
387 | Ubiquitination | DLSRSSRGELIPISP HCCCCCCCCEEECCC | 35.69 | - | |
393 | Phosphorylation | RGELIPISPSTEVGG CCCEEECCCCCCCCC | 13.88 | 23401153 | |
395 | Phosphorylation | ELIPISPSTEVGGSG CEEECCCCCCCCCCC | 30.34 | 30266825 | |
396 | Phosphorylation | LIPISPSTEVGGSGI EEECCCCCCCCCCCC | 37.77 | 30266825 | |
401 | Phosphorylation | PSTEVGGSGIGTPPS CCCCCCCCCCCCCHH | 22.70 | 22167270 | |
405 | Phosphorylation | VGGSGIGTPPSVLKR CCCCCCCCCHHHHHH | 30.06 | 22167270 | |
408 | Phosphorylation | SGIGTPPSVLKRQRK CCCCCCHHHHHHHHH | 41.08 | 22167270 | |
411 | Ubiquitination | GTPPSVLKRQRKRRV CCCHHHHHHHHHCCE | 44.31 | - | |
411 | Sumoylation | GTPPSVLKRQRKRRV CCCHHHHHHHHHCCE | 44.31 | 28112733 | |
421 | Phosphorylation | RKRRVALSPVTENST HHCCEEECCCCCCCC | 13.95 | 29255136 | |
424 | Phosphorylation | RVALSPVTENSTSLS CEEECCCCCCCCCCH | 32.60 | 29255136 | |
427 | Phosphorylation | LSPVTENSTSLSFLD ECCCCCCCCCCHHHH | 17.09 | 25850435 | |
428 | Phosphorylation | SPVTENSTSLSFLDS CCCCCCCCCCHHHHH | 45.31 | 25850435 | |
429 | Phosphorylation | PVTENSTSLSFLDSC CCCCCCCCCHHHHHC | 23.10 | 28464451 | |
431 | Phosphorylation | TENSTSLSFLDSCNS CCCCCCCHHHHHCCC | 24.43 | 26074081 | |
435 | Phosphorylation | TSLSFLDSCNSLTPK CCCHHHHHCCCCCCC | 19.83 | 29255136 | |
438 | Phosphorylation | SFLDSCNSLTPKSTP HHHHHCCCCCCCCCC | 37.64 | 29255136 | |
440 | Phosphorylation | LDSCNSLTPKSTPVK HHHCCCCCCCCCCCC | 28.61 | 29255136 | |
443 | Phosphorylation | CNSLTPKSTPVKTLP CCCCCCCCCCCCCCC | 38.86 | - | |
444 | Phosphorylation | NSLTPKSTPVKTLPF CCCCCCCCCCCCCCC | 37.92 | 10095772 | |
447 | Ubiquitination | TPKSTPVKTLPFSPS CCCCCCCCCCCCCHH | 45.61 | - | |
447 | Sumoylation | TPKSTPVKTLPFSPS CCCCCCCCCCCCCHH | 45.61 | 28112733 | |
448 | Phosphorylation | PKSTPVKTLPFSPSQ CCCCCCCCCCCCHHH | 39.64 | 22199227 | |
452 | Phosphorylation | PVKTLPFSPSQFLNF CCCCCCCCHHHHHHH | 23.00 | 25159151 | |
454 | Phosphorylation | KTLPFSPSQFLNFWN CCCCCCHHHHHHHHC | 32.16 | 28450419 | |
465 | Phosphorylation | NFWNKQDTLELESPS HHHCCCCCEEECCCC | 21.46 | - | |
470 | Phosphorylation | QDTLELESPSLTSTP CCCEEECCCCCCCCC | 32.20 | 29083192 | |
472 | Phosphorylation | TLELESPSLTSTPVC CEEECCCCCCCCCCC | 54.26 | 29083192 | |
474 | Phosphorylation | ELESPSLTSTPVCSQ EECCCCCCCCCCCCC | 34.59 | 28348404 | |
475 | Phosphorylation | LESPSLTSTPVCSQK ECCCCCCCCCCCCCE | 35.69 | 29083192 | |
475 | Ubiquitination | LESPSLTSTPVCSQK ECCCCCCCCCCCCCE | 35.69 | 29967540 | |
476 | Phosphorylation | ESPSLTSTPVCSQKV CCCCCCCCCCCCCEE | 17.95 | 27050516 | |
480 | Phosphorylation | LTSTPVCSQKVVVTT CCCCCCCCCEEEEEC | 33.02 | 29083192 | |
482 | Sumoylation | STPVCSQKVVVTTPL CCCCCCCEEEEECCC | 22.24 | 28112733 | |
485 | Ubiquitination | VCSQKVVVTTPLHRD CCCCEEEEECCCCCC | 5.74 | 29967540 | |
486 | Phosphorylation | CSQKVVVTTPLHRDK CCCEEEEECCCCCCC | 15.87 | 30266825 | |
487 | Phosphorylation | SQKVVVTTPLHRDKT CCEEEEECCCCCCCC | 16.55 | 30266825 | |
494 | Phosphorylation | TPLHRDKTPLHQKHA CCCCCCCCCCCCCCE | 35.06 | 30576142 | |
499 | Ubiquitination | DKTPLHQKHAAFVTP CCCCCCCCCEEEECC | 25.18 | 29967540 | |
499 | Sumoylation | DKTPLHQKHAAFVTP CCCCCCCCCEEEECC | 25.18 | 28112733 | |
504 | Ubiquitination | HQKHAAFVTPDQKYS CCCCEEEECCCCCCC | 6.96 | 29967540 | |
505 | Phosphorylation | QKHAAFVTPDQKYSM CCCEEEECCCCCCCC | 18.07 | 30266825 | |
509 | Sumoylation | AFVTPDQKYSMDNTP EEECCCCCCCCCCCC | 46.82 | - | |
509 | Sumoylation | AFVTPDQKYSMDNTP EEECCCCCCCCCCCC | 46.82 | 28112733 | |
509 | Ubiquitination | AFVTPDQKYSMDNTP EEECCCCCCCCCCCC | 46.82 | 29967540 | |
509 | Acetylation | AFVTPDQKYSMDNTP EEECCCCCCCCCCCC | 46.82 | - | |
509 | Ubiquitination | AFVTPDQKYSMDNTP EEECCCCCCCCCCCC | 46.82 | - | |
510 | Phosphorylation | FVTPDQKYSMDNTPH EECCCCCCCCCCCCC | 12.00 | 26074081 | |
511 | Phosphorylation | VTPDQKYSMDNTPHT ECCCCCCCCCCCCCC | 27.05 | 26074081 | |
515 | Phosphorylation | QKYSMDNTPHTPTPF CCCCCCCCCCCCCCC | 16.51 | 28450419 | |
518 | Phosphorylation | SMDNTPHTPTPFKNA CCCCCCCCCCCCHHH | 30.02 | 25159151 | |
520 | Phosphorylation | DNTPHTPTPFKNALE CCCCCCCCCCHHHHH | 42.38 | 22617229 | |
522 | Ubiquitination | TPHTPTPFKNALEKY CCCCCCCCHHHHHHH | 11.95 | 29967540 | |
523 | Ubiquitination | PHTPTPFKNALEKYG CCCCCCCHHHHHHHC | 42.38 | 29967540 | |
523 | Sumoylation | PHTPTPFKNALEKYG CCCCCCCHHHHHHHC | 42.38 | 28112733 | |
528 | Ubiquitination | PFKNALEKYGPLKPL CCHHHHHHHCCCCCC | 57.25 | 29967540 | |
529 | Phosphorylation | FKNALEKYGPLKPLP CHHHHHHHCCCCCCC | 18.01 | 23312004 | |
533 | Acetylation | LEKYGPLKPLPQTPH HHHHCCCCCCCCCCC | 47.87 | 23749302 | |
533 | Ubiquitination | LEKYGPLKPLPQTPH HHHHCCCCCCCCCCC | 47.87 | 29967540 | |
533 | Sumoylation | LEKYGPLKPLPQTPH HHHHCCCCCCCCCCC | 47.87 | 28112733 | |
538 | Phosphorylation | PLKPLPQTPHLEEDL CCCCCCCCCCHHHHH | 15.67 | 25159151 | |
546 | Sumoylation | PHLEEDLKEVLRSEA CCHHHHHHHHHHHHH | 59.09 | - | |
546 | Sumoylation | PHLEEDLKEVLRSEA CCHHHHHHHHHHHHH | 59.09 | 28112733 | |
546 | Ubiquitination | PHLEEDLKEVLRSEA CCHHHHHHHHHHHHH | 59.09 | 29967540 | |
560 | Ubiquitination | AGIELIIEDDIRPEK HCEEEEECCCCCHHH | 42.51 | 29967540 | |
577 | Phosphorylation | RKPGLRRSPIKKVRK CCCCCCCCHHHHHHH | 25.25 | 28112733 | |
584 | Ubiquitination | SPIKKVRKSLALDIV CHHHHHHHHHHHHHC | 53.46 | 29967540 | |
584 | Sumoylation | SPIKKVRKSLALDIV CHHHHHHHHHHHHHC | 53.46 | 28112733 | |
585 | Phosphorylation | PIKKVRKSLALDIVD HHHHHHHHHHHHHCC | 14.33 | 22199227 | |
596 | Sumoylation | DIVDEDVKLMMSTLP HHCCHHHHHHHHHCC | 42.88 | - | |
596 | Sumoylation | DIVDEDVKLMMSTLP HHCCHHHHHHHHHCC | 42.88 | 28112733 | |
600 | Phosphorylation | EDVKLMMSTLPKSLS HHHHHHHHHCCCCCC | 16.90 | 20068231 | |
601 | Ubiquitination | DVKLMMSTLPKSLSL HHHHHHHHCCCCCCC | 29.23 | 29967540 | |
601 | Phosphorylation | DVKLMMSTLPKSLSL HHHHHHHHCCCCCCC | 29.23 | 20068231 | |
615 | Ubiquitination | LPTTAPSNSSSLTLS CCCCCCCCCCCEEEE | 44.87 | 29967540 | |
615 | Acetylation | LPTTAPSNSSSLTLS CCCCCCCCCCCEEEE | 44.87 | - | |
624 | Ubiquitination | SSLTLSGIKEDNSLL CCEEEECHHHCCCHH | 3.87 | 29967540 | |
625 | Sumoylation | SLTLSGIKEDNSLLN CEEEECHHHCCCHHH | 63.64 | 28112733 | |
625 | Ubiquitination | SLTLSGIKEDNSLLN CEEEECHHHCCCHHH | 63.64 | 29967540 | |
629 | Phosphorylation | SGIKEDNSLLNQGFL ECHHHCCCHHHCCCC | 46.70 | 25159151 | |
639 | Sumoylation | NQGFLQAKPEKAAVA HCCCCCCCHHHHHHC | 40.52 | - | |
639 | Sumoylation | NQGFLQAKPEKAAVA HCCCCCCCHHHHHHC | 40.52 | 28112733 | |
639 | Ubiquitination | NQGFLQAKPEKAAVA HCCCCCCCHHHHHHC | 40.52 | 29967540 | |
639 | Acetylation | NQGFLQAKPEKAAVA HCCCCCCCHHHHHHC | 40.52 | 23236377 | |
648 | Ubiquitination | EKAAVAQKPRSHFTT HHHHHCCCCHHHCCC | 32.43 | 29967540 | |
648 | Acetylation | EKAAVAQKPRSHFTT HHHHHCCCCHHHCCC | 32.43 | 25953088 | |
648 | Sumoylation | EKAAVAQKPRSHFTT HHHHHCCCCHHHCCC | 32.43 | 28112733 | |
654 | Phosphorylation | QKPRSHFTTPAPMSS CCCHHHCCCCCCCCC | 26.84 | 26074081 | |
655 | Phosphorylation | KPRSHFTTPAPMSSA CCHHHCCCCCCCCCC | 19.26 | 26074081 | |
660 | Phosphorylation | FTTPAPMSSAWKTVA CCCCCCCCCCCCCHH | 18.82 | 26074081 | |
661 | Phosphorylation | TTPAPMSSAWKTVAC CCCCCCCCCCCCHHC | 31.71 | 26074081 | |
693 | Phosphorylation | GRLKPSHTSRTLILS CCCCCCCCCCEEECC | 25.00 | - | |
695 | Methylation | LKPSHTSRTLILS-- CCCCCCCCEEECC-- | 34.41 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
18 | T | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
440 | T | Phosphorylation | Kinase | CDK2 | P24941 | Uniprot |
444 | T | Phosphorylation | Kinase | CDK2 | P24941 | Uniprot |
487 | T | Phosphorylation | Kinase | CDK2 | P24941 | Uniprot |
494 | T | Phosphorylation | Kinase | CDK2 | P24941 | Uniprot |
520 | T | Phosphorylation | Kinase | CDK2 | P24941 | Uniprot |
577 | S | Phosphorylation | Kinase | CDK2 | P24941 | Uniprot |
- | K | Ubiquitination | E3 ubiquitin ligase | SKP2 | Q13309 | PMID:10871850 |
- | K | Ubiquitination | E3 ubiquitin ligase | CDC34 | P49427 | PMID:22199232 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
520 | T | Phosphorylation |
| 10095772 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MYBB_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ZN622_HUMAN | ZNF622 | physical | 12645566 | |
CDN1C_HUMAN | CDKN1C | physical | 12947099 | |
CBP_HUMAN | CREBBP | genetic | 11423988 | |
PARP1_HUMAN | PARP1 | physical | 10744766 | |
CCNA1_HUMAN | CCNA1 | physical | 11264176 | |
MYBB_HUMAN | MYBL2 | physical | 10544265 | |
CDK9_HUMAN | CDK9 | genetic | 10656684 | |
CCNT1_HUMAN | CCNT1 | genetic | 10656684 | |
CDK9_HUMAN | CDK9 | physical | 10656684 | |
LZTR1_HUMAN | LZTR1 | physical | 20211142 | |
TRI15_HUMAN | TRIM15 | physical | 20211142 | |
ZBTB9_HUMAN | ZBTB9 | physical | 20211142 | |
LIN54_HUMAN | LIN54 | physical | 17671431 | |
LIN9_HUMAN | LIN9 | physical | 17671431 | |
LIN37_HUMAN | LIN37 | physical | 17671431 | |
RBBP4_HUMAN | RBBP4 | physical | 17671431 | |
RBL1_HUMAN | RBL1 | physical | 17671431 | |
LIN9_HUMAN | LIN9 | physical | 17159899 | |
FLNA_HUMAN | FLNA | physical | 18548008 | |
SPTA1_HUMAN | SPTA1 | physical | 18548008 | |
CLH1_HUMAN | CLTC | physical | 18548008 | |
SPTB2_HUMAN | SPTBN1 | physical | 18548008 | |
CLCA_HUMAN | CLTA | physical | 18548008 | |
LIN9_HUMAN | LIN9 | physical | 18548008 | |
UB2D4_HUMAN | UBE2D4 | physical | 21988832 | |
CCNF_HUMAN | CCNF | physical | 25557911 | |
PA24A_HUMAN | PLA2G4A | physical | 14769798 | |
EPAS1_HUMAN | EPAS1 | physical | 28394947 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-241 AND THR-405, ANDMASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-241, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-393, AND MASSSPECTROMETRY. | |
"Identification of cyclin A/Cdk2 phosphorylation sites in B-Myb."; Bartsch O., Horstmann S., Toprak K., Klempnauer K.H., Ferrari S.; Eur. J. Biochem. 260:384-391(1999). Cited for: PHOSPHORYLATION AT THR-440; THR-444; THR-494; THR-520 AND SER-577. | |
"The cell-cycle regulated transcription factor B-Myb is phosphorylatedby cyclin A/Cdk2 at sites that enhance its transactivationproperties."; Saville M.K., Watson R.J.; Oncogene 17:2679-2689(1998). Cited for: PHOSPHORYLATION AT THR-444; THR-487; THR-494 AND SER-577. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-266, AND MASSSPECTROMETRY. |